本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BridgeBio Pharma, Inc.

76.75
-0.7600-0.98%
盤後76.750.00000.00%19:41 EDT
成交量:204.48萬
成交額:1.57億
市值:148.79億
市盈率:-20.30
高:79.62
開:79.60
低:75.65
收:77.51
52周最高:84.94
52周最低:31.77
股本:1.94億
流通股本:1.51億
量比:1.19
換手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):-3.7800
每股收益(LYR):-3.7850
淨資產收益率:-1789.67%
總資產收益率:-33.83%
市淨率:-7.13
市盈率(LYR):-20.28

資料載入中...

2025/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

重要事件披露

Form 8-K - Current report
2025/07/02

重要事件披露

Form 8-K - Current report
2025/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/23

重要事件披露

Form 8-K - Current report
2025/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities